| |
| |
|
| Insider
Information: |
Squinto Stephen P |
| Relationship: |
Director, 10% Owner |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
238,160 |
|
|
Indirect Shares
|
6,290,493 |
|
|
| Direct
Value |
$19,437,710 |
|
|
|
Indirect Value
|
$19,013,945 |
|
|
| Total
Shares |
6,528,653 |
|
|
| Total
Value |
$38,451,655 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Global Ops.... |
2014-10-27 |
106,508 |
2013-10-28 |
104,186 |
Premium* |
|
|
Springworks Therapeutics, Inc. |
SWTX |
Director, 10% Owner |
2022-05-19 |
131,652 |
2022-05-19 |
6,186,307 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
148 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2005-05-02 |
4 |
AS |
$20.32 |
$1,189,127 |
D/D |
(57,343) |
4,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
officerTitle |
• – – |
2006-01-09 |
4 |
A |
$20.72 |
$82,880 |
D/D |
4,000 |
8,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2006-02-15 |
4 |
AS |
$35.00 |
$175,116 |
D/D |
(5,000) |
8,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2004-12-20 |
4 |
AS |
$25.00 |
$361,995 |
D/D |
(14,440) |
11,876 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2006-04-07 |
4 |
A |
$0.00 |
$0 |
D/D |
4,272 |
12,272 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2006-11-13 |
4 |
AS |
$42.76 |
$342,175 |
D/D |
(8,000) |
12,272 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP, Head of Research |
• – – |
2004-12-21 |
4 |
A |
$0.00 |
$0 |
D/D |
467 |
12,343 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2006-02-15 |
4 |
OE |
$10.50 |
$52,500 |
D/D |
5,000 |
13,000 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2007-11-05 |
4 |
AS |
$75.03 |
$2,625,900 |
D/D |
(34,998) |
13,772 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Executive VP/Head of Research |
• – – |
2004-05-10 |
4 |
AS |
$21.01 |
$105,050 |
D/D |
(5,000) |
15,476 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Executive VP& Head of Research |
• – – |
2004-08-16 |
4 |
S |
$15.30 |
$153,000 |
D/D |
(10,000) |
15,476 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2007-03-12 |
4 |
AS |
$37.15 |
$28,160 |
D/D |
(758) |
15,514 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2007-04-03 |
4 |
AS |
$43.52 |
$413,673 |
D/D |
(9,500) |
15,514 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research & Devel |
• – – |
2008-07-10 |
4 |
S |
$75.75 |
$12,044 |
D/D |
(159) |
15,742 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• • – |
2005-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
15,876 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2008-03-10 |
4 |
S |
$56.05 |
$8,912 |
D/D |
(159) |
15,901 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research & Devel |
• – – |
2008-05-19 |
4 |
AS |
$69.72 |
$2,501,336 |
D/D |
(35,827) |
15,901 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2008-01-10 |
4 |
S |
$69.02 |
$49,142 |
D/D |
(712) |
16,060 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2007-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
4,000 |
16,272 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2008-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
16,772 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2006-11-13 |
4 |
OE |
$10.50 |
$84,000 |
D/D |
8,000 |
20,272 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2007-09-10 |
4 |
AS |
$65.31 |
$13,650 |
D/D |
(209) |
20,303 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Executive VP/Head of Research |
• – – |
2004-02-09 |
4 |
AS |
$20.58 |
$102,875 |
D/D |
(5,000) |
20,476 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
EVP & Head of Research |
• – – |
2007-07-25 |
4 |
AS |
$56.50 |
$1,414,306 |
D/D |
(25,000) |
20,512 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Executive VP& Head of Research |
• – – |
2004-08-16 |
4 |
OE |
$2.38 |
$43,047 |
D/D |
18,125 |
23,601 |
|
- |
|
148 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
